Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.

One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui, emphasized its global ambitions and plans ...

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

A new crop of companies is lining up to buy patient data from hospitals and sell it to those wanting to train AI or do ...

UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.

At the J.P. Morgan Health Care conference, the future outlook for GLP-1 drugs used to treat obesity was a key focus, ...

As researchers push for a type 1 diabetes cure, Sana Biotechnology has provided a nudge forward with new, if limited, ...

Cancer deaths overall are falling, but the burden is shifting toward younger adults and women, the American Cancer Society ...

Rounds reports on the FDA banning red dye no. 3 and curbing nicotine levels; a study showing meat associated with dementia ...

STAT spoke with researcher Carol Haywood about her new study that looked at the persistent ableism in medicine and its root ...

A new study highlights the potential of a therapeutic strategy focused on stopping or slowing Huntington's disease ...

Under proposals from congressional Republicans, Medicaid would be transformed into a much more limited welfare program.